Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Post by GoldenInvestoron May 20, 2020 9:30am
70 Views
Post# 31050627

Covid-19 Vaccine production +ve implications - CNBC

Covid-19 Vaccine production +ve implications - CNBCThis morning CNBC discussing the need for manufacturing facilities to make whatever vaccine in discovered' in large quantities.

They discussed the use of contract MANUFACTURING facilities.

a benefit of having GBT incorporated into KNIGHT shows great forward thinking of management.

GUD could contribute to that manufacturing  and/or keep in mind that other pharmaceuticals still need to be produced.  

Therefore, the could be a huge opportunity to produce other medicine/ acquire new ignored products or be a contributor to COVID vaccines - ignored products, a JRG focus

In GUD GBT facility!
Bullboard Posts